Alternatives to Maves

A rare needle-free option at true price parity — $79/mo semaglutide or $133/mo tirzepatide, injectable or oral, same price — though NuuVim frames it as a new-patient rate with an unpublished refill tier, and its 50-state coverage claim couldn't be confirmed on its own live site this pass.

• $10/mo cheaper than Maves
• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded

Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.

• publishes a price for both molecules, which Maves does not
• has an oral option if you would rather not inject
• scores 75/100 against Maves's 34

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

• publishes a price for both molecules, which Maves does not
• has an oral option if you would rather not inject
• scores 80/100 against Maves's 34

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Shapely is the first provider in this batch that takes insurance — it says it is in network with Medicare and major PPO plans, and quotes brand-name co-pays of "typically $25 per month". That genuinely changes the arithmetic for anyone with coverage. What has to be read carefully is what the membership buys: $99 a month, $49 for the first, and it explicitly does not include medications or labs. So the compounded prices, $99 for semaglutide and $166 for tirzepatide, sit on top of the membership rather than replacing it.

• publishes a price for both molecules, which Maves does not
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

• $20/mo cheaper than Maves
• publishes a price for both molecules, which Maves does not
• scores 56/100 against Maves's 34

The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens.

• $10/mo cheaper than Maves
• publishes a price for both molecules, which Maves does not
• has an oral option if you would rather not inject

A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.

• publishes a price for both molecules, which Maves does not
• scores 76/100 against Maves's 34